{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:56:05Z","timestamp":1790582165663,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2023M741281"],"award-info":[{"award-number":["2023M741281"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Research Fund of Hubei Key Laboratory of Precision Radiation Oncology","award":["jzfs009"],"award-info":[{"award-number":["jzfs009"]}]},{"name":"Opening Foundation of State Key Laboratory of Neurology and Oncology Drug Development","award":["SKLSIM-20251426"],"award-info":[{"award-number":["SKLSIM-20251426"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"DOI":"10.1007\/s40291-026-00875-0","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:13:33Z","timestamp":1790579613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of Diagnostic Models and Biomarker Identification for Type 1 Leptomeningeal Metastasis in Lung Adenocarcinoma Using Olink: Exploratory Cohort Study with Internal Temporal Validation"],"prefix":"10.1007","author":[{"given":"Peng","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuchi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Kui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohua","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"875_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2022.09.013","volume":"174","author":"Y Wang","year":"2022","unstructured":"Wang Y, Yang X, Li NJ, Xue JX. Leptomeningeal metastases in non-small cell lung cancer: diagnosis and treatment. Lung Cancer. 2022;174:1\u201313. https:\/\/doi.org\/10.1016\/j.lungcan.2022.09.013.","journal-title":"Lung Cancer"},{"key":"875_CR2","doi-asserted-by":"publisher","first-page":"e500","DOI":"10.1016\/j.wneu.2022.11.050","volume":"170","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li J, Liu T, Ge M, Ji X, Chu Z, et al. Clinical outcomes of patients with epidermal growth factor receptor-mutated non-small-cell lung cancer with leptomeningeal metastasis in the modern target therapy era. World Neurosurg. 2023;170:e500\u20139. https:\/\/doi.org\/10.1016\/j.wneu.2022.11.050.","journal-title":"World Neurosurg"},{"key":"875_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.723562","volume":"11","author":"N Li","year":"2022","unstructured":"Li N, Bian Z, Cong M, Liu Y. Survival outcomes of patients with epidermal growth factor receptor mutations in non-small cell lung cancer with leptomeningeal metastasis. Front Oncol. 2022;11:723562. https:\/\/doi.org\/10.3389\/fonc.2021.723562.","journal-title":"Front Oncol"},{"key":"875_CR4","doi-asserted-by":"publisher","unstructured":"Le Rhun E, Weller M, van den Bent M, Brandsma D, Furtner J, Rud\u00e0 R, Schadendorf D, Seoane J, Tonn JC, Wesseling P, Wick W, Minniti G, Peters S, Curigliano G, Preusser M; EANO Guidelines Committee and ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Leptomeningeal metastasis from solid tumours: EANO-ESMO clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open. 2023;8:101624. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101624.","DOI":"10.1016\/j.esmoop.2023.101624"},{"key":"875_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/1078-0432.CCR-22-1585","volume":"29","author":"G Ozcan","year":"2023","unstructured":"Ozcan G, Singh M, Vredenburgh JJ. Leptomeningeal metastasis from non-small cell lung cancer and current landscape of treatments. Clin Cancer Res. 2023;29:11\u201329. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-1585.","journal-title":"Clin Cancer Res"},{"key":"875_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11060-023-04519-9","volume":"165","author":"JH Wijaya","year":"2023","unstructured":"Wijaya JH, Patel UD, Quintero-Consuegra MD, Aguilera-Pe\u00f1a MP, Madri\u00f1\u00e1n-Navia HJ, Putra AW, et al. Liquid biopsy in the setting of leptomeningeal metastases: a systematic review and meta-analysis. J Neurooncol. 2023;165:431\u20138. https:\/\/doi.org\/10.1007\/s11060-023-04519-9.","journal-title":"J Neurooncol"},{"key":"875_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bj\u00f6rkesten J, Thorsen SB, Ekman D, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. 2014;9:e95192. https:\/\/doi.org\/10.1371\/journal.pone.0095192.","journal-title":"PLoS ONE"},{"key":"875_CR8","doi-asserted-by":"publisher","unstructured":"Jiaxu, Zhao Rui, Zeng Xiaohui, Li Ying, Lu Zuoyun, Wang Haibao, Peng Hao, Chen Minjie, Fu Ye, Zhang Yang, Huang Wenhan, Chen Xin, Wang Yun, Guan Wei, Han Ruofan, Huang Chengjun, Yao Zhiyong, Qin Lingchao, Chen Liang, Chen Xue, Feng Hanting, Yang Patr\u00edcia M. R., Pereira Xuemei, Tong Bin, Li Qiangqiang, Zhang Yudan, Chi (2024) Dura immunity configures leptomeningeal metastasis immunosuppression for cerebrospinal fluid barrier invasion Nature Cancer 5(12) 1940-1961\u00a0 https:\/\/doi.org\/10.1038\/s43018-024-00858-2","DOI":"10.1038\/s43018-024-00858-2"},{"issue":"6","key":"875_CR9","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.3390\/curroncol30060442","volume":"30","author":"A Nguyen","year":"2023","unstructured":"Nguyen A, Nguyen A, Dada OT, Desai PD, Ricci JC, Godbole NB, et al. Leptomeningeal metastasis: a review of the pathophysiology, diagnostic methodology, and therapeutic landscape. Curr Oncol. 2023;30(6):5906\u201331. https:\/\/doi.org\/10.3390\/curroncol30060442.","journal-title":"Curr Oncol"},{"issue":"6","key":"875_CR10","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3171\/2022.8.JNS22744","volume":"138","author":"IA Tewarie","year":"2022","unstructured":"Tewarie IA, Senko AW, Jessurun CAC, Zhang AT, Hulsbergen AFC, Rendon L, et al. Predicting leptomeningeal disease spread after resection of brain metastases using machine learning. J Neurosurg. 2022;138(6):1561\u20139. https:\/\/doi.org\/10.3171\/2022.8.JNS22744.","journal-title":"J Neurosurg"},{"key":"875_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1339914","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Chen K, Li J, Tang X, Ruan H, Guan M. Diagnostic value of cerebrospinal fluid human epididymis protein 4 for leptomeningeal metastasis in lung adenocarcinoma. Front Immunol. 2024;15:1339914. https:\/\/doi.org\/10.3389\/fimmu.2024.1339914.","journal-title":"Front Immunol"},{"key":"875_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2467870","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Tian C, Shi Q, Hao J, Zhao N, Liu Z. Diagnostic value of CYFRA 21-1 in the cerebrospinal fluid for leptomeningeal metastasis. Dis Markers. 2017. https:\/\/doi.org\/10.1155\/2017\/2467870.","journal-title":"Dis Markers"},{"key":"875_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.664420","volume":"12","author":"X Wu","year":"2022","unstructured":"Wu X, Xing P, Shi M, Guo W, Zhao F, Zhu H, et al. Cerebrospinal fluid cell-free DNA-based detection of high level of genomic instability is associated with poor prognosis in NSCLC patients with leptomeningeal metastases. Front Oncol. 2022;12:664420. https:\/\/doi.org\/10.3389\/fonc.2022.664420.","journal-title":"Front Oncol"},{"key":"875_CR14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/annonc\/mdy009","volume":"29","author":"YS Li","year":"2018","unstructured":"Li YS, Jiang BY, Yang JJ, Zhang XC, Zhang Z, Ye JY, et al. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy. Ann Oncol. 2018;29:945\u201352. https:\/\/doi.org\/10.1093\/annonc\/mdy009.","journal-title":"Ann Oncol"},{"key":"875_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-01218-8","volume":"10","author":"H Fang","year":"2025","unstructured":"Fang H, Luo H, Li S, Yan N, Xu S, Liu N, et al. Serial monitoring of cerebrospinal fluid in patients with leptomeningeal metastases in lung cancer via the Ommaya reservoir as a predictive indicator of therapeutic efficacy and clinical prognosis. NPJ Precis Oncol. 2025;10:21. https:\/\/doi.org\/10.1038\/s41698-025-01218-8.","journal-title":"NPJ Precis Oncol"},{"key":"875_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000004636","author":"X Xu","year":"2026","unstructured":"Xu X, Xu C, Zeng N, Sun Q, Xu F, Ma J, et al. Plasma proteomic markers predict risk for bowel resection in inflammatory bowel disease: a retrospective cohort study. Int J Surg. 2026. https:\/\/doi.org\/10.1097\/JS9.0000000000004636.","journal-title":"Int J Surg"},{"key":"875_CR17","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41416-025-03229-5","volume":"133","author":"WZ Wu","year":"2025","unstructured":"Wu WZ, Huang HC, Zhu GH, Liao LD, Chen XL, Li ZM, et al. Serum multiomics prediction of prognosis and adverse reactions to concurrent chemoradiotherapy in patients with esophageal cancer. Br J Cancer. 2025;133:1829\u201343. https:\/\/doi.org\/10.1038\/s41416-025-03229-5.","journal-title":"Br J Cancer"},{"key":"875_CR18","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1158\/1078-0432","volume":"27","author":"I Smalley","year":"2021","unstructured":"Smalley I, Chen Z, Phadke M, Li J, Yu X, Wyatt C, et al. Single-cell characterization of the immune microenvironment of melanoma brain and leptomeningeal metastases. Clin Cancer Res. 2021;27:4109\u201325. https:\/\/doi.org\/10.1158\/1078-0432.","journal-title":"Clin Cancer Res"},{"key":"875_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41568-024-00700-y","volume":"24","author":"J Remsik","year":"2024","unstructured":"Remsik J, Boire A. The path to leptomeningeal metastasis. Nat Rev Cancer. 2024;24:448\u201360. https:\/\/doi.org\/10.1038\/s41568-024-00700-y.","journal-title":"Nat Rev Cancer"},{"key":"875_CR20","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/s41586-025-09012-z","volume":"643","author":"J Remsik","year":"2025","unstructured":"Remsik J, Tong X, Kunes RZ, Li MJ, Estrera R, Snyder J, et al. Interferon-\u03b3 orchestrates leptomeningeal anti-tumour response. Nature. 2025;643:1087\u201396. https:\/\/doi.org\/10.1038\/s41586-025-09012-z.","journal-title":"Nature"},{"key":"875_CR21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201562","volume":"217","author":"I Melero","year":"2020","unstructured":"Melero I, Berraondo P. 4-1BB (CD137) in anticancer chimeras. J Exp Med. 2020;217:e20201562. https:\/\/doi.org\/10.1084\/jem.20201562.","journal-title":"J Exp Med"},{"key":"875_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-000733","volume":"4","author":"I Etxeberria","year":"2020","unstructured":"Etxeberria I, Glez-Vaz J, Teijeira \u00c1, Melero I. New emerging targets in cancer immunotherapy: CD137\/4-1BB costimulatory axis. ESMO Open. 2020;4:e000733. https:\/\/doi.org\/10.1136\/esmoopen-2020-000733.","journal-title":"ESMO Open"},{"key":"875_CR23","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1158\/1078-0432.CCR-24-1568","volume":"30","author":"P Molero-Glez","year":"2024","unstructured":"Molero-Glez P, Azpilikueta A, Mosteo L, Glez-Vaz J, Palencia B, Melero I. CD137 (4\u20131BB) and T-lymphocyte exhaustion. Clin Cancer Res. 2024;30:3971\u20133. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-1568.","journal-title":"Clin Cancer Res"},{"key":"875_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126210","volume":"22","author":"AG Martinez-Perez","year":"2021","unstructured":"Martinez-Perez AG, Perez-Trujillo JJ, Garza-Morales R, Loera-Arias MJ, Saucedo-Cardenas O, Garcia-Garcia A, et al. 4-1BBL as a mediator of cross-talk between innate, adaptive, and regulatory immunity against cancer. Int J Mol Sci. 2021;22:6210. https:\/\/doi.org\/10.3390\/ijms22126210.","journal-title":"Int J Mol Sci"},{"key":"875_CR25","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00262-016-1829-2","volume":"65","author":"C Chester","year":"2016","unstructured":"Chester C, Ambulkar S, Kohrt HE. 4-1BB agonism: adding the accelerator to cancer immunotherapy. Cancer Immunol Immunother. 2016;65:1243\u20138. https:\/\/doi.org\/10.1007\/s00262-016-1829-2.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"875_CR26","first-page":"31","volume":"1","author":"Y Sun","year":"2004","unstructured":"Sun Y, Chen JH, Fu Y. Immunotherapy with agonistic anti-CD137: two sides of a coin. Cell Mol Immunol. 2004;1(1):31\u20136.","journal-title":"Cell Mol Immunol"},{"key":"875_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/sj.cgt.7700670","volume":"11","author":"AT Cheuk","year":"2004","unstructured":"Cheuk AT, Mufti GJ, Guinn BA. Role of 4-1BB:4-1BB ligand in cancer immunotherapy. Cancer Gene Ther. 2004;11:215\u201326. https:\/\/doi.org\/10.1038\/sj.cgt.7700670.","journal-title":"Cancer Gene Ther"},{"key":"875_CR28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/cts.12553","volume":"11","author":"Y He","year":"2018","unstructured":"He Y, Ao DH, Li XQ, Zhong SS, A R, Wang YY, et al. Increased soluble CD137 levels and CD4+ T-cell-associated expression of CD137 in acute atherothrombotic stroke. Clin Transl Sci. 2018;11:428\u201334. https:\/\/doi.org\/10.1111\/cts.12553.","journal-title":"Clin Transl Sci"},{"issue":"3","key":"875_CR29","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.7150\/ijbs.66781","volume":"18","author":"H Wei","year":"2022","unstructured":"Wei H, Chen L, Li Q, Liang X, Wang K, Zhang Y, et al. CD137L-macrophage induce lymphatic endothelial cells autophagy to promote lymphangiogenesis in renal fibrosis. Int J Biol Sci. 2022;18(3):1171\u201387. https:\/\/doi.org\/10.7150\/ijbs.66781.","journal-title":"Int J Biol Sci"},{"key":"875_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2167189","volume":"15","author":"C Claus","year":"2023","unstructured":"Claus C, Ferrara-Koller C, Klein C. The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy. MAbs. 2023;15:2167189. https:\/\/doi.org\/10.1080\/19420862.2023.2167189.","journal-title":"MAbs"},{"key":"875_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.975926","volume":"13","author":"YT Wang","year":"2022","unstructured":"Wang YT, Ji WD, Jiao HM, Lu A, Chen KF, Liu QB. Targeting 4\u20131BB for tumor immunotherapy from bench to bedside. Front Immunol. 2022;13:975926. https:\/\/doi.org\/10.3389\/fimmu.2022.975926.","journal-title":"Front Immunol"},{"key":"875_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052730","volume":"22","author":"J Seidel","year":"2021","unstructured":"Seidel J, Leitzke S, Ahrens B, Sperrhacke M, Bhakdi S, Reiss K. Role of ADAM10 and ADAM17 in regulating CD137 function. Int J Mol Sci. 2021;22:2730. https:\/\/doi.org\/10.3390\/ijms22052730.","journal-title":"Int J Mol Sci"},{"key":"875_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1062967","volume":"5","author":"S Labiano","year":"2015","unstructured":"Labiano S, Palaz\u00f3n A, Bola\u00f1os E, Azpilikueta A, S\u00e1nchez-Paulete AR, Morales-Kastresana A, et al. Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism. Oncoimmunology. 2015;5:e1062967. https:\/\/doi.org\/10.1080\/2162402X.2015.1062967.","journal-title":"Oncoimmunology"},{"key":"875_CR34","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.immuni.2023.06.007","volume":"56","author":"AC Pichler","year":"2023","unstructured":"Pichler AC, Carri\u00e9 N, Cuisinier M, Ghazali S, Voisin A, Axisa PP, et al. TCR-independent CD137 (4-1BB) signaling promotes CD8+-exhausted T cell proliferation and terminal differentiation. Immunity. 2023;56:1631-1648.e10. https:\/\/doi.org\/10.1016\/j.immuni.2023.06.007.","journal-title":"Immunity"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-026-00875-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-026-00875-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-026-00875-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:13:34Z","timestamp":1790579614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-026-00875-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":34,"alternative-id":["875"],"URL":"https:\/\/doi.org\/10.1007\/s40291-026-00875-0","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was supported by the China Postdoctoral Science Foundation (2023M741281), the Open Research Fund of Hubei Key Laboratory of Precision Radiation Oncology (jzfs009), and the Opening Foundation of State Key Laboratory of Neurology and Oncology Drug Development (SKLSIM-20251426).","order":1,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no potential conflicts of interest in the research, authorship, and publication of this article.","order":2,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conceptualization: Peng Ding and QiuChi Chen; data curation: QiuChi Chen and Yun Li; formal analysis: Peng Ding, Yun Li, and Minghui Ge; funding acquisition: Peng Ding and Xiaorong Dong; investigation: Qiuchi Chen; methodology: Qiuchi Chen and Yun Li; project administration: Ruiguang Zhang and Xing Zhang; resources: Hongxia Zhou, Bohua Kuang, and Lingjuan Chen; software: Yun Li; supervision: Fan Tong; validation: Yulan Kui and Zhi Wang; visualization: Minghui Ge and Tiantian Han; writing\u2014original draft: Peng Ding, Qiuchi Chen, and Yulan Kui; writing\u2014review and editing: Ruiguang Zhang, Fan Tong, and Xiaorong Dong. All authors have read and approved the final manuscript.","order":3,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Wuhan Union Hospital (19 January 2024; No.: [2024; 0003]).","order":4,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have contributed to the creation of this manuscript for intellectual content, and read and approved the final manuscript.","order":6,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the research results have been presented in the article. The raw data supporting the findings of this study can be made available from the corresponding author upon reasonable request.","order":7,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The code used will be made available upon request.","order":8,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}}]}}